Optimized Ablation of the Posterior Wall in Persistent Atrial Fibrillation — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Optimized Ablation of the Posterior Wall in Persistent Atrial Fibrillation — Stella

Home/Persistent Atrial Fibrillation/

View on ClinicalTrials.gov

Recruiting

Back to Persistent Atrial Fibrillation trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

China

Shanghai Chest Hospital, Shanghai

Key details

Sponsor

Shanghai Chest Hospital

Enrollment target

~384 participants

Started

July 2025

Primary completion

December 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 80 Years

Last updated August 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.